Navigation Links
National Cancer Institute renews Cancer Center designation for Huntsman Cancer Institute
Date:12/30/2010

Salt Lake City, December 30, 2010Officials at Huntsman Cancer Institute (HCI) at the University of Utah announced that the National Cancer Institute (NCI) has renewed its prestigious designation as a Cancer Center. The NCI designation recognizes the outstanding cancer research conducted at HCI, which holds the only such designation in the five-state Intermountain West and is the only NCI-designated Cancer Center within 500 miles of Salt Lake City.

"I am tremendously proud of the physicians, scientists, and administrative staff at HCI that have made this renewal possible," says Jon M. Huntsman, HCI's founding benefactor. "This highly prestigious designation includes only the nation's elite cancer institutions, those that demonstrate exceptional ability to conduct cancer research. As part of the renewal process, HCI was evaluated by a team of 30 national cancer experts during a competitive grant review and site visit. HCI received the strongest rating in its history and was ranked in the "High Impact" category."

The NCI designation recognizes the pivotal role of research in the development of improvements in cancer detection, diagnosis, treatment, and prevention and is reserved only for Cancer Centers that achieve the highest standards of excellence in cancer research. HCI received the prestigious NCI designation following a rigorous scientific review and evaluation of performance and expertise in several essential elements, including the quality and impact of the Center's cancer research, the availability of state-of-the art research and patient care facilities, experienced scientific leadership, and the level of collaboration and translation of science to innovative cancer care.

HCI's research excellence has been made possible by generous support of the Huntsman family and the Huntsman Cancer Foundation which supports HCI's research mission via philanthropic contributions. An outstanding ten-member External Advisory Board provides planning and evaluation direction to HCI, and includes such luminaries as Dr. Edward Benz, President of the Dana-Farber Cancer Institute of Harvard University and Nobel Laureate, Dr. Elizabeth Blackburn of the University of California at San Francisco.

"The highly laudatory review of HCI's programs by thought leaders in cancer research affirms the innovation and impact of our cancer research efforts. NCI designation brings financial resources to support further development of our research infrastructure, ensuring that we have cutting-edge technologies and expertise," says Mary Beckerle, Ph.D., HCI's executive director. "The national recognition of our accomplishments and potential for future excellence allows us to attract top faculty and additional grant support for cancer research."

HCI currently has 135 faculty researchers and more than $60 million in extramural grants. Considered a world leader in the study of cancer genetics, HCI researchers have earned international recognition for their work to identify the gene mutations responsible for colon cancer, breast and ovarian cancer, melanoma, neurofibromatosis, and, most recently, hereditary paraganglioma. A strategic focus of HCI is to leverage genetic understanding of cancer to personalize cancer risk assessment, diagnosis, and treatment.

"I have had the privilege of visiting HCI on many occasions since it was established," says Utah Sen. Orrin Hatch. "The recent NCI review confirms HCI's status as an elite cancer research center, its commitment to excellence, and the significant impact it has had in the cancer research field. The research performed there provides real hope and lifesaving results for cancer patients and their families."


'/>"/>

Contact: Ashlee Harrison
ashlee.harrison@hci.utah.edu
801-585-1954
University of Utah Health Sciences
Source:Eurekalert

Related biology news :

1. Biophysical Society announces winners of 2011 International Travel Awards
2. Dodds contributes to new national study on nitrogen water pollution
3. SU biologist partners with National Park Service to study bison grazing in Yellowstone
4. Pacific Northwest National Laboratorys 2010 AGU tip sheet
5. National team of scientists peers into the future of stem cell biology
6. University of Illinois awarded National Science Foundation grant to mentor Latino students
7. Ravenous foreign pests threaten national treasures
8. George W. Sledge, Jr., M.D., honored for international contributions to breast cancer research
9. MU cancer scientists form new company with international pharmaceutical firm
10. Scientists propose new international cancer effort akin to Human Genome Project
11. Story tips from the Department of Energys Oak Ridge National Laboratory -- December 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: